Delivery Order SPE2DB22D2005-SPE2DB26FJEV5
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,124.96 for 100 tablets of Premarin 0.45 mg on October 30, 2025, with completion expected by October 31, 2025. This is a firm fixed-price, non-competitive delivery order with no set-aside designation, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,179.95 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) with a firm fixed price arrangement. This delivery order, issued on September 24, 2025, with completion expected by September 25, 2025, represents a non-set-aside competitive award under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical supply will be...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Premarin 0.625 mg tablets (100 count) under a firm fixed-price contract structure. This non-set-aside award carries a ceiling value of $1,905.17 and has an ultimate completion date of August 8, 2025. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery order represents a discrete...
- The Defense Logistics Agency awarded a delivery order valued at $3,396.33 to AmerisourceBergen Drug Corp for 100 tablets of Premarin 0.625 mg on October 14, 2025, with completion scheduled for October 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100-count units) on August 28, 2025, with a ceiling value of $1,252.52 and an ultimate completion date of August 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Premarin 0.3 mg tablets in quantities of 100, with a contract ceiling value of $3,740.12 and a firm fixed price structure. This delivery order represents a non-set-aside competitive award and is scheduled for ultimate completion by September 29, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,692.86 to AmerisourceBergen Drug Corp for the supply of Premarin 0.625 mg tablets (100 count) on October 23, 2025, with an ultimate completion date of October 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and serves as a critical vendor for...
- The Defense Logistics Agency awarded a $2,045.53 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Premarin 0.3 mg tablets (100-unit quantity). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 22, 2025. The contract is performed out of AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,725.43 to AmerisourceBergen Drug Corp for the supply of Premarin 0.3 mg tablets (100-count units) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $4,119.57 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Premarin 0.3 mg on July 14, 2025, with completion expected by July 15, 2025. This is a firm fixed-price contract with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB26FJEV5Delivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,192.55 for 100 tablets of Premarin 0.625 mg on October 29, 2025, with an ultimate completion date of October 30, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated significant capability in meeting federal procurement requirements through open competition and consistently fulfills diverse medical supply needs across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/29/25 |